Literature DB >> 23108103

Acute carbonyl stress induces occludin glycation and brain microvascular endothelial barrier dysfunction: role for glutathione-dependent metabolism of methylglyoxal.

Wei Li1, Ronald E Maloney, Magdalena L Circu, J Steven Alexander, Tak Yee Aw.   

Abstract

We recently demonstrated that methylglyoxal (MG) induced apoptosis of brain microvascular endothelial cells (IHECs) that was preceded by glutathione (GSH) depletion. Here, we test the hypothesis that MG induces occludin glycation and disrupts IHEC barrier function, which is prevented by GSH-dependent MG metabolism. Exposure of IHECs to MG decreased transendothelial electrical resistance (TEER) in association with MG-adduct formation. A 65-kDa MG-glycated protein corresponded to occludin, which was confirmed by immunoprecipitation. Moreover, immunofluorescence staining showed that MG disrupted the architectural organization of ZO-1. Occludin glycation and ZO-1 disruption were prevented by N-acetylcysteine (NAC). Accordingly, TEER loss was abrogated by NAC (via GSH synthesis) and exacerbated by buthionine sulfoximine (BSO; GSH synthesis inhibitor). BSO treatment attenuated D-lactate production, consistent with a role for GSH in glyoxalase I-catalyzed MG elimination. Although MG increased reactive oxygen species (ROS) generation, the ROS scavengers tempol and tiron did not block barrier disruption. This suggests that endogenously generated ROS were unlikely to be a major cause of or did not reach a threshold to elicit barrier failure as elicited by exogenous hydrogen peroxide (300-400 μM). Immunohistochemistry revealed a lower percentage of microvessels stained with anti-occludin, but a higher percentage stained with anti-MG in diabetic rat brain compared to controls. Western analyses confirmed the decrease in diabetic brain occludin expression, but an increase in glycated occludin levels. These results provide novel evidence that reactive carbonyl species can mediate occludin glycation in cerebral microvessels and in microvascular endothelial cells that contribute to barrier dysfunction, a process that was prevented by GSH through enhanced MG catabolism.
Copyright © 2012 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23108103      PMCID: PMC3742316          DOI: 10.1016/j.freeradbiomed.2012.10.552

Source DB:  PubMed          Journal:  Free Radic Biol Med        ISSN: 0891-5849            Impact factor:   7.376


  47 in total

1.  H(2)O(2)-mediated permeability: role of MAPK and occludin.

Authors:  C G Kevil; T Oshima; B Alexander; L L Coe; J S Alexander
Journal:  Am J Physiol Cell Physiol       Date:  2000-07       Impact factor: 4.249

2.  The effects of methylglyoxal on glutathione S-transferase from Nicotiana tabacum.

Authors:  Md Anamul Hoque; Misugi Uraji; Mst Nasrin Akhter Banu; Izumi C Mori; Yoshimasa Nakamura; Yoshiyuki Murata
Journal:  Biosci Biotechnol Biochem       Date:  2010-10-07       Impact factor: 2.043

3.  Methylglyoxal and high glucose co-treatment induces apoptosis or necrosis in human umbilical vein endothelial cells.

Authors:  Wen-Hsiung Chan; Hsin-Jung Wu
Journal:  J Cell Biochem       Date:  2008-03-01       Impact factor: 4.429

4.  Preservation of cellular glutathione status and mitochondrial membrane potential by N-acetylcysteine and insulin sensitizers prevent carbonyl stress-induced human brain endothelial cell apoptosis.

Authors:  Masahiro Okouchi; Naotsuka Okayama; Tak Yee Aw
Journal:  Curr Neurovasc Res       Date:  2009-11       Impact factor: 1.990

5.  Methylglyoxal causes strong weakening of detoxifying capacity and apoptotic cell death in rat hippocampal neurons.

Authors:  Silvia Di Loreto; Vincenzo Zimmitti; Pierluigi Sebastiani; Carla Cervelli; Stefano Falone; Fernanda Amicarelli
Journal:  Int J Biochem Cell Biol       Date:  2007-08-08       Impact factor: 5.085

Review 6.  Protein and nucleotide damage by glyoxal and methylglyoxal in physiological systems--role in ageing and disease.

Authors:  Paul J Thornalley
Journal:  Drug Metabol Drug Interact       Date:  2008

7.  Advanced glycation end products in extracellular matrix proteins contribute to the failure of sensory nerve regeneration in diabetes.

Authors:  Beatriz Duran-Jimenez; Darin Dobler; Sarah Moffatt; Naila Rabbani; Charles H Streuli; Paul J Thornalley; David R Tomlinson; Natalie J Gardiner
Journal:  Diabetes       Date:  2009-08-31       Impact factor: 9.461

8.  Adaptive cerebral neovascularization in a model of type 2 diabetes: relevance to focal cerebral ischemia.

Authors:  Weiguo Li; Roshini Prakash; Aisha I Kelly-Cobbs; Safia Ogbi; Anna Kozak; Azza B El-Remessy; Derek A Schreihofer; Susan C Fagan; Adviye Ergul
Journal:  Diabetes       Date:  2009-10-06       Impact factor: 9.461

9.  Reductive metabolism of AGE precursors: a metabolic route for preventing AGE accumulation in cardiovascular tissue.

Authors:  Shahid P Baba; Oleg A Barski; Yonis Ahmed; Timothy E O'Toole; Daniel J Conklin; Aruni Bhatnagar; Sanjay Srivastava
Journal:  Diabetes       Date:  2009-08-03       Impact factor: 9.461

10.  Impact of methylglyoxal and high glucose co-treatment on human mononuclear cells.

Authors:  Ming-Shu Hsieh; Wen-Hsiung Chan
Journal:  Int J Mol Sci       Date:  2009-03-31       Impact factor: 6.208

View more
  18 in total

1.  The protection conferred against ischemia-reperfusion injury in the diabetic brain by N-acetylcysteine is associated with decreased dicarbonyl stress.

Authors:  Bin Wang; Tak Yee Aw; Karen Y Stokes
Journal:  Free Radic Biol Med       Date:  2016-04-12       Impact factor: 7.376

2.  Normobaric Hyperoxia Extends Neuro- and Vaso-Protection of N-Acetylcysteine in Transient Focal Ischemia.

Authors:  Yushan Liu; Wen-Cao Liu; Yanyun Sun; Xianzhi Shen; Xiaona Wang; Hui Shu; Rong Pan; Chun-Feng Liu; Wenlan Liu; Ke Jian Liu; Xinchun Jin
Journal:  Mol Neurobiol       Date:  2016-05-13       Impact factor: 5.590

Review 3.  Neuroinflammation Involved in Diabetes-Related Pain and Itch.

Authors:  Xiao-Xia Fang; Heng Wang; Hao-Lin Song; Juan Wang; Zhi-Jun Zhang
Journal:  Front Pharmacol       Date:  2022-06-20       Impact factor: 5.988

4.  A comparison of reversible versus irreversible protein glutathionylation.

Authors:  Danyelle M Townsend; Volodymyr I Lushchak; Arthur J L Cooper
Journal:  Adv Cancer Res       Date:  2014       Impact factor: 6.242

5.  Activation of the integrated stress response in nociceptors drives methylglyoxal-induced pain.

Authors:  Paulino Barragán-Iglesias; Jasper Kuhn; Guadalupe C Vidal-Cantú; Ana Belen Salinas-Abarca; Vinicio Granados-Soto; Gregory O Dussor; Zachary T Campbell; Theodore J Price
Journal:  Pain       Date:  2019-01       Impact factor: 7.926

6.  Methylglyoxal induces mitochondrial dysfunction and cell death in liver.

Authors:  Kyuhwa Seo; Sung Hwan Ki; Sang Mi Shin
Journal:  Toxicol Res       Date:  2014-09

7.  High glucose, glucose fluctuation and carbonyl stress enhance brain microvascular endothelial barrier dysfunction: Implications for diabetic cerebral microvasculature.

Authors:  Wei Li; Ronald E Maloney; Tak Yee Aw
Journal:  Redox Biol       Date:  2015-04-02       Impact factor: 11.799

8.  Methylglyoxal induces systemic symptoms of irritable bowel syndrome.

Authors:  Shuang Zhang; Taiwei Jiao; Yushuai Chen; Nan Gao; Lili Zhang; Min Jiang
Journal:  PLoS One       Date:  2014-08-26       Impact factor: 3.240

9.  Metabolic Serum Profiles for Patients Receiving Allogeneic Stem Cell Transplantation: The Pretransplant Profile Differs for Patients with and without Posttransplant Capillary Leak Syndrome.

Authors:  Håkon Reikvam; Ida-Sofie Grønningsæter; Aymen Bushra Ahmed; Kimberley Hatfield; Øystein Bruserud
Journal:  Dis Markers       Date:  2015-11-02       Impact factor: 3.434

10.  Edaravone protects against methylglyoxal-induced barrier damage in human brain endothelial cells.

Authors:  Andrea E Tóth; Fruzsina R Walter; Alexandra Bocsik; Petra Sántha; Szilvia Veszelka; Lajos Nagy; László G Puskás; Pierre-Olivier Couraud; Fuyuko Takata; Shinya Dohgu; Yasufumi Kataoka; Mária A Deli
Journal:  PLoS One       Date:  2014-07-17       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.